150 related articles for article (PubMed ID: 24098713)
41. Lifelong prevention of mesangial enlargement by whole pancreas transplantation in rats with diabetes mellitus.
Orloff LA; Orloff MS; Orloff SL; Orloff MJ
Arch Surg; 1999 Aug; 134(8):889-97. PubMed ID: 10443814
[TBL] [Abstract][Full Text] [Related]
42. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
[TBL] [Abstract][Full Text] [Related]
43. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.
Franzén S; Friederich-Persson M; Fasching A; Hansell P; Nangaku M; Palm F
Am J Physiol Renal Physiol; 2014 May; 306(10):F1171-8. PubMed ID: 24623147
[TBL] [Abstract][Full Text] [Related]
44. Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats.
Sayed AA; Khalifa M; Abd el-Latif FF
J Physiol Biochem; 2012 Jun; 68(2):263-9. PubMed ID: 22237966
[TBL] [Abstract][Full Text] [Related]
45. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
46. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
47. The 67kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG.
Fujimura Y; Umeda D; Yano S; Maeda-Yamamoto M; Yamada K; Tachibana H
Biochem Biophys Res Commun; 2007 Dec; 364(1):79-85. PubMed ID: 17927962
[TBL] [Abstract][Full Text] [Related]
48. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
49. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
Sutariya B; Saraf M
J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
[TBL] [Abstract][Full Text] [Related]
50. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
51. The parathyroid hormone-related protein system and diabetic nephropathy outcome in streptozotocin-induced diabetes.
Izquierdo A; López-Luna P; Ortega A; Romero M; Guitiérrez-Tarrés MA; Arribas I; Alvarez MJ; Esbrit P; Bosch RJ
Kidney Int; 2006 Jun; 69(12):2171-7. PubMed ID: 16783882
[TBL] [Abstract][Full Text] [Related]
52. Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril.
Mostafa DK; Khedr MM; Barakat MK; Abdellatif AA; Elsharkawy AM
Life Sci; 2021 Jan; 265():118818. PubMed ID: 33275985
[TBL] [Abstract][Full Text] [Related]
53. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model.
Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F
J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462
[TBL] [Abstract][Full Text] [Related]
54. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice.
Matsushita Y; Ogawa D; Wada J; Yamamoto N; Shikata K; Sato C; Tachibana H; Toyota N; Makino H
Diabetes; 2011 Mar; 60(3):960-8. PubMed ID: 21270242
[TBL] [Abstract][Full Text] [Related]
55. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
56. Glucose-induced decrease of cystathionine β-synthase mediates renal injuries.
Yu Y; Xiao L; Ren Z; Zhu G; Wang W; Jia Y; Peng A; Wang X
FASEB J; 2021 May; 35(5):e21576. PubMed ID: 33864412
[TBL] [Abstract][Full Text] [Related]
57. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
[TBL] [Abstract][Full Text] [Related]
58. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
59. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
Ishibashi Y; Matsui T; Taira J; Higashimoto Y; Yamagishi S
Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
[TBL] [Abstract][Full Text] [Related]
60. Assessment of DNA damage and lipid peroxidation in diabetic mice: effects of propolis and epigallocatechin gallate (EGCG).
Oršolić N; Sirovina D; Gajski G; Garaj-Vrhovac V; Jazvinšćak Jembrek M; Kosalec I
Mutat Res; 2013 Sep; 757(1):36-44. PubMed ID: 23859956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
